Copayment accumulators and maximizers have the potential to harm patients’ access to necessary medicines. Health care payers (including employers, insurers, and pharmacy benefit managers), regulators, ...

Health Affairs' Senior Deputy Editor Rob Lott interviews Erica Eliason of Rutgers University on her recent paper that explores how continuous eligibility policies and the Children's Health Insurance ...

Regulatory and reimbursement pathways should consider indirect benefits in addition to direct health benefits when evaluating ...